Health
16 Oct 2026
Microbiotica Secures £36 Million to Advance Gut‑Bacteria Therapy for Ulcerative Colitis
The UK‑based microbiome company has raised £36 million to bring its live‑bacteria capsule into a Phase 2 trial, offering a potential new treatment that does not suppress the immune system.
Read more